0000320335-23-000027.txt : 20230503 0000320335-23-000027.hdr.sgml : 20230503 20230503164100 ACCESSION NUMBER: 0000320335-23-000027 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 15 CONFORMED PERIOD OF REPORT: 20230503 ITEM INFORMATION: Results of Operations and Financial Condition ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20230503 DATE AS OF CHANGE: 20230503 FILER: COMPANY DATA: COMPANY CONFORMED NAME: GLOBE LIFE INC. CENTRAL INDEX KEY: 0000320335 STANDARD INDUSTRIAL CLASSIFICATION: LIFE INSURANCE [6311] IRS NUMBER: 630780404 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-08052 FILM NUMBER: 23884812 BUSINESS ADDRESS: STREET 1: 3700 SOUTH STONEBRIDGE DRIVE CITY: MCKINNEY STATE: TX ZIP: 75070 BUSINESS PHONE: 972-569-4000 MAIL ADDRESS: STREET 1: 3700 SOUTH STONEBRIDGE DRIVE CITY: MCKINNEY STATE: TX ZIP: 75070 FORMER COMPANY: FORMER CONFORMED NAME: TORCHMARK CORP DATE OF NAME CHANGE: 19920703 FORMER COMPANY: FORMER CONFORMED NAME: TORCHMARK CORP SAVINGS & INVESTMENT PLAN DATE OF NAME CHANGE: 19820825 FORMER COMPANY: FORMER CONFORMED NAME: LIBERTY NATIONAL INSURANCE HOLDING CO DATE OF NAME CHANGE: 19820701 8-K 1 gl-20230503.htm 8-K (Q1 2023 EARNINGS RELEASE) gl-20230503
0000320335false00003203352023-05-032023-05-030000320335us-gaap:CommonStockMember2023-05-032023-05-030000320335us-gaap:SubordinatedDebtMember2023-05-032023-05-03

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): May 3, 2023
GLOBE LIFE INC.
(Exact name of registrant as specified in its charter)
Delaware 001-0805263-0780404
(State or other jurisdiction
of incorporation)
 
(Commission
File No.)
(I.R.S. Employer
ID No.)
3700 South Stonebridge Drive, McKinney, Texas 75070
(Address of principal executive offices) (Zip Code)
Registrant’s telephone number, including area code: (972569-4000
N/A
(Former name or former address, if changed since last report)
 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a.-12)
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:
Title of each classTrading Symbol(s)Name of each exchange on which registered
Common Stock, $1.00 par value per shareGLNew York Stock Exchange
4.250% Junior Subordinated DebenturesGL PRDNew York Stock Exchange

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter):
Emerging growth company
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.




Item 2.02    Results of Operations and Financial Condition.
On May 3, 2023, Globe Life Inc. issued a press release announcing its first quarter 2023 financial results. A copy of the press release is incorporated herein by reference and is provided as Exhibit 99.1.
In accordance with General Instruction B.2 of Form 8-K, the information included or incorporated in this report (including Exhibit 99.1) shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934 (the “Exchange Act”), nor shall such information be deemed incorporated by reference in any filing under the Securities Act of 1933 or the Exchange Act, except as shall be set forth by specific reference in such filing.
Item 9.01    Financial Statement and Exhibits.
(a)Financial Statements of businesses or funds acquired.
Not applicable.
(b)Pro forma financial information.
Not applicable.
(c)Shell company transactions.
Not applicable
(d)Exhibits.
(104) Cover Page Interactive Data File (embedded within the Inline XBRL document)






SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
 
Date: May 3, 2023
 GLOBE LIFE INC.
 /s/ Christopher T. Moore
 Christopher T. Moore

Corporate Senior Vice President,
Associate Counsel and Corporate Secretary


EX-99.1 2 q1fy2023earningsrelease.htm EX-99.1 Document

globelifeheadera.gif

GLOBE LIFE INC. REPORTS
First Quarter 2023 Results


McKinney, TX, May 3, 2023—Globe Life Inc. (NYSE: GL) reported today that for the quarter ended March 31, 2023, net income was $2.28 per diluted common share, compared with $2.37 per diluted common share for the year-ago quarter. Net operating income for the quarter was $2.53 per diluted common share, compared with $2.43 per diluted common share for the year-ago quarter.

The results included herein reflect the adoption of ASU 2018-12, Financial Services - Insurance (Topic 944): Targeted Improvements to the Accounting for Long-Duration Contracts (LDTI). Globe Life Inc. implemented the standard on January 1, 2023 using the modified retrospective transition method at adoption. As a result of this election, the prior year figures have been restated as of January 1, 2021 with impacts to Shareholders' Equity, underwriting margins and net income.

HIGHLIGHTS:
l
Net income as an ROE was 22.9% for the three months ended March 31, 2023. Net operating income as an ROE excluding accumulated other comprehensive income (AOCI) was 14.6% for the same period.
l
At the Liberty National Division, life net sales and health net sales increased over the year-ago quarter by 27% and 14%, respectively. Additionally, life premiums increased 6% and the average producing agent count increased 13% over the year-ago quarter.
l
At the Family Heritage Division, health premiums increased 7% and health net sales increased 21% over the year-ago quarter. Additionally, the average producing agent count increased 18% over the year-ago quarter.
lAt the American Income Life Division, life premiums increased 5% over the year-ago quarter. Additionally, the average producing agent count increased 4% over the year-ago quarter.
l1.2 million shares of Globe Life Inc. common stock were repurchased during the quarter.











Note: As used in the earnings release, "Globe Life," the "Company," "we," "our," and "us" refer to Globe Life Inc., a Delaware corporation incorporated in 1979, its subsidiaries and affiliates.
1
GL Q1 2023 Earnings Release

GLOBE LIFE INC.
Earnings Release—Q1 2023
(Dollar amounts in thousands, except share and per share data)
(Unaudited)
RESULTS OF OPERATIONS

Net operating income, a non-GAAP(1) financial measure, has been used consistently by Globe Life’s management for many years to evaluate the operating performance of the Company, and is a measure commonly used in the life insurance industry. It differs from net income primarily because it excludes certain non-operating items such as realized investment gains and losses and certain significant and unusual items included in net income. Management believes an analysis of net operating income is important in understanding the profitability and operating trends of the Company’s business. Net income is the most directly comparable GAAP measure.

The following table represents Globe Life's operating summary for the three months ended March 31, 2023 and 2022:
Operating Summary
Per Share
Three Months Ended
March 31,
Three Months Ended
March 31,
20232022%
Chg.
20232022%
Chg.
Insurance underwriting income(2)
$3.18 $3.07 4$311,037 $307,326 1
Excess investment income(2)
0.30 0.26 1529,255 25,825 13
Interest on debt(0.25)(0.20)25(24,867)(19,944)25
Parent Company expense(0.03)(0.03)(2,585)(2,640)
Income tax expense(0.61)(0.61)(59,849)(61,083)(2)
Stock compensation benefit (expense), net of tax(0.05)(0.06)(4,949)(6,189)
Net operating income 2.53 2.43 4248,042 243,295 2
Reconciling items, net of tax:
Realized gain (loss)—investments(0.25)(0.06)(24,432)(5,723)
Non-operating expenses— — — (88)
Net income(3)
$2.28 $2.37 $223,610 $237,484 
Weighted average diluted shares outstanding 97,911 100,250 
(1)GAAP is defined as accounting principles generally accepted in the United States of America.
(2)Definitions included within this document.
(3)A GAAP-basis condensed consolidated statement of operations is included in the appendix of this report.


Note: Tables in this earnings release may not sum due to rounding.

2
GL Q1 2023 Earnings Release

GLOBE LIFE INC.
Earnings Release—Q1 2023
(Dollar amounts in thousands, except share and per share data)
(Unaudited)
MANAGEMENT VS. GAAP MEASURES

Shareholders' equity, excluding AOCI, and book value per share, excluding AOCI, are non-GAAP measures that are utilized by management to view the business without the effect of changes in AOCI, which are primarily attributable to fluctuation in interest rates. Management views the business in this manner because it creates more meaningful and easily identifiable trends, as we exclude fluctuations resulting from changes in interest rates. Shareholders' equity and book value per share are the most directly comparable GAAP measures.
Three Months Ended
March 31,
20232022
Net income as an ROE(1)
22.9 %41.8 %
Net operating income as an ROE (excluding AOCI)
14.6 %15.4 %
March 31,
20232022
Shareholders' equity$3,846,291 $2,544,275 
Impact of adjustment to exclude AOCI2,961,093 3,827,006 
Shareholders' equity, excluding AOCI$6,807,384 $6,371,281 
Book value per share$39.74 $25.52 
Impact of adjustment to exclude AOCI30.60 38.39 
Book value per share, excluding AOCI$70.34 $63.91 
(1) Calculated using average shareholders' equity for the measurement period.

INSURANCE OPERATIONS:

Life insurance accounted for 76% of the Company’s insurance underwriting margin for the quarter and 71% of total premium revenue.

Health insurance accounted for 24% of the Company's insurance underwriting margin for the quarter and 29% of total premium revenue.

Net sales of life insurance increased 1% for the quarter and net health sales increased 17%.

The following table summarizes Globe Life's premium revenue by product type for the three months ended March 31, 2023 and 2022:
Insurance Premium Revenue
Quarter Ended
March 31, 2023March 31, 2022%
Chg.
Life insurance$772,597 $749,128 3
Health insurance322,493 315,684 2
Annuity— — 
Total$1,095,090 $1,064,812 3


3
GL Q1 2023 Earnings Release

GLOBE LIFE INC.
Earnings Release—Q1 2023
(Dollar amounts in thousands, except share and per share data)
(Unaudited)
INSURANCE UNDERWRITING INCOME

Insurance underwriting margin is management’s measure of profitability of the Company's life, health, and annuity segments’ underwriting performance, and consists of premiums less policy obligations (excluding interest on policy liabilities), commissions and other acquisition expenses. Insurance underwriting income is the sum of the insurance underwriting margins of the life, health, and annuity segments, plus other income, less administrative expenses. It excludes the investment segment, interest on debt, Parent Company expense, stock compensation expense and income taxes. Management believes this information helps provide a better understanding of the business and a more meaningful analysis of underwriting results by distribution channel. Insurance underwriting income, a non-GAAP measure, is a component of net operating income, which is reconciled to net income in the Results of Operations section above.

The following table summarizes Globe Life's insurance underwriting income by segment for the three months ended March 31, 2023 and 2022:
Insurance Underwriting Income
Quarter Ended
March 31, 2023% of
Premium
March 31, 2022% of
Premium
%
Chg.
Insurance underwriting margins:
Life$291,274 38$289,594 391
Health91,332 2887,870 284
Annuity2,288 2,263 
384,894 379,727 1
Other income50 164 
Administrative expenses(73,907)(72,565)2
Insurance underwriting income$311,037 $307,326 1
Per share$3.18 $3.07 4

The ratio of administrative expenses to premium was 6.7%, compared with 6.8% for the year-ago quarter.

4
GL Q1 2023 Earnings Release

GLOBE LIFE INC.
Earnings Release—Q1 2023
(Dollar amounts in thousands, except share and per share data)
(Unaudited)
LIFE INSURANCE RESULTS BY DISTRIBUTION CHANNEL

Our distribution channels consist of the following exclusive agencies: American Income Life Division (American Income), Liberty National Division (Liberty National) and Family Heritage Division (Family Heritage); an independent agency, United American Division (United American); and our Direct to Consumer Division (Direct to Consumer).

Total premium, underwriting margins, first-year collected premium and net sales by all distribution channels are shown at https://investors.globelifeinsurance.com at "Financial Reports and Other Financial Information."
Life Underwriting Margin
Quarter Ended
March 31,
20232022
Amount% of PremiumAmount% of Premium% Chg.
American Income $175,567 45 $172,817 47 2
Direct to Consumer 56,161 23 58,038 24 (3)
Liberty National 27,690 32 26,936 33 3
Other 31,856 61 31,803 60 
Total$291,274 38 $289,594 39 1
Life Premium
Quarter Ended
March 31,
20232022%
Chg.
American Income $387,512 $370,106 5
Direct to Consumer 247,667 245,732 1
Liberty National 85,203 80,560 6
Other 52,215 52,730 (1)
Total$772,597 $749,128 3
Life Net Sales(1)
Quarter Ended
March 31,
20232022%
Chg.
American Income $83,329 $85,350 (2)
Direct to Consumer 32,467 33,913 (4)
Liberty National 21,979 17,365 27
Other 2,594 2,375 9
Total$140,369 $139,003 1
(1)Net sales, a statistical performance measure, is calculated as annualized premium issued, net of cancellations in the first thirty days after issue, except in the case of Direct to Consumer, where net sales is annualized premium issued at the time the first full premium is paid after any introductory offer period has expired. Management considers net sales to be a better indicator of the rate of premium growth than annualized premium issued.

5
GL Q1 2023 Earnings Release

GLOBE LIFE INC.
Earnings Release—Q1 2023
(Dollar amounts in thousands, except share and per share data)
(Unaudited)
HEALTH INSURANCE RESULTS BY DISTRIBUTION CHANNEL
Health Underwriting Margin
Quarter Ended
March 31,
20232022
Amount% of PremiumAmount% of Premium% Chg.
United American $12,938 10 $13,391 10 (3)
Family Heritage 31,749 33 27,712 31 15
Liberty National 26,870 57 27,744 58 (3)
American Income 18,386 62 18,320 64 
Direct to Consumer1,389 703 98
Total$91,332 28 $87,870 28 4
Health Premium
Quarter Ended
March 31,
20232022%
Chg.
United American $132,607 $131,690 1
Family Heritage 96,072 89,540 7
Liberty National 46,972 47,760 (2)
American Income 29,594 28,766 3
Direct to Consumer 17,248 17,928 (4)
Total$322,493 $315,684 2
Health Net Sales(1)
Quarter Ended
March 31,
20232022%
Chg.
United American $15,380 $12,970 19
Family Heritage 22,543 18,602 21
Liberty National 7,096 6,214 14
American Income 4,504 4,621 (3)
Direct to Consumer 550 421 31
Total$50,073 $42,828 17
(1)Net sales, a statistical performance measure, is calculated as annualized premium issued, net of cancellations in the first thirty days after issue, except in the case of Direct to Consumer, where net sales is annualized premium issued at the time the first full premium is paid after any introductory offer period has expired. Management considers net sales to be a better indicator of the rate of premium growth than annualized premium issued.

6
GL Q1 2023 Earnings Release

GLOBE LIFE INC.
Earnings Release—Q1 2023
(Dollar amounts in thousands, except share and per share data)
(Unaudited)
PRODUCING EXCLUSIVE AGENT COUNT RESULTS BY DISTRIBUTION CHANNEL

Quarterly Average
Producing Agent Count(1)
Quarter EndedQuarter Ended
March 31,December 31,
20232022% Chg.2022
American Income9,714 9,385 9,243 
Liberty National 3,011 2,656 13 2,946 
Family Heritage 1,298 1,100 18 1,334 

(1) The quarterly average producing agent count is based on the actual count at the end of each week during the period.


INVESTMENTS

Management uses excess investment income as the measure to evaluate the performance of the investment segment. It is defined as net investment income less the required interest attributable to policy liabilities. We also view excess investment income per diluted common share as an important and useful measure to evaluate performance of the investment segment, since it takes into consideration our stock repurchase program.

The following table summarizes Globe Life's investment income, excess investment income, and excess investment income per diluted common share.
Excess Investment Income
Quarter Ended
March 31,
20232022%
Chg.
Net investment income$257,105 $244,894 5
Interest on policy liabilities(1)
(227,850)(219,069)4
Excess investment income$29,255 $25,825 13
Per share$0.30 $0.26 15
(1)Interest on policy liabilities is a component of total policyholder benefits, a GAAP measure. The amounts presented for 2022 have been retrospectively adjusted to exclude the interest on deferred acquisition costs due to the LDTI standard and the interest on debt.

Net investment income increased 5.0%, and average invested assets increased 3.5%. Required interest on policy liabilities increased 4.0%, and average policy liabilities increased 4.3%.
7
GL Q1 2023 Earnings Release

GLOBE LIFE INC.
Earnings Release—Q1 2023
(Dollar amounts in thousands, except share and per share data)
(Unaudited)
The composition of the investment portfolio at book value at March 31, 2023 is as follows:
Investment Portfolio
As of
March 31, 2023
Amount% of Total
Fixed maturities at fair value(1)
$17,206,885 91 
Policy loans622,736 
Other long-term investments(2)
1,022,611 
Short-term investments74,377 — 
Total$18,926,609 
(1) As of March 31, 2023, fixed maturities at amortized cost were $18.5 billion, net of $33 million of allowance for credit losses.
(2) Includes $789 million of investments accounted for under the fair value option which have a cost of $783 million as of March 31, 2023.

Fixed maturities at amortized cost, net of allowance for credit losses, by asset class as of March 31, 2023 are as follows:
Fixed Maturity Portfolio by Sector
As of
March 31, 2023
Investment GradeBelow Investment GradeTotal Amortized Cost, net
Corporate bonds$14,485,367 $546,434 $15,031,801 
Municipals2,894,161 — 2,894,161 
Government, agencies and GSEs443,230 — 443,230 
Collateralized debt obligations— 36,778 36,778 
Other asset-backed securities75,579 12,387 87,966 
Total$17,898,337 $595,599 $18,493,936 
Below are fixed maturities available for sale by amortized cost, allowance for credit losses, and fair value at March 31, 2023 and the corresponding amounts of net unrealized gains and losses recognized in accumulated other comprehensive income (loss).
As of
Amortized
Cost
Allowance for Credit LossesNet Unrealized Gains (Losses)Fair
 Value
March 31, 2023
$18,526,703 $(32,767)$(1,287,051)$17,206,885 

At amortized cost, net of allowance for credit losses, 97% of fixed maturities (97% at fair value) were rated “investment grade.” The fixed maturity portfolio earned an annual taxable equivalent effective yield of 5.18% during the first quarter of 2023, compared with 5.15% in the year-ago quarter.

Globe Life is not a party to any credit default swaps and does not participate in securities lending. In the first quarter, the Company recorded an allowance for credit losses, as shown above, primarily as a result of Signature Bank going into receivership. The Company did not have any outstanding holdings with Silicon Valley Bank. Subsequent to March 31, 2023, it was announced First Republic Bank had entered receivership effective April 30, 2023. As of March 31, 2023, the Company had $38.6 million outstanding with First Republic Bank with no associated allowance for credit losses. We have provided additional information regarding our banking and CML investments on our Investor Relations website under Financial Reports and Other Financial Information.


8
GL Q1 2023 Earnings Release

GLOBE LIFE INC.
Earnings Release—Q1 2023
(Dollar amounts in thousands, except share and per share data)
(Unaudited)
Comparable information for acquisitions of fixed maturity investments is as follows:
Fixed Maturity Acquisitions
Quarter Ended
March 31,
20232022
Amount$310,504 $351,215 
Average annual effective yield5.8 %4.0 %
Average ratingAA
Average life (in years) to:
Next call19.7 15.8 
Maturity24.9 26.9 

SHARE REPURCHASE:

During the quarter, the Company repurchased 1.2 million shares of Globe Life Inc. common stock at a total cost of $135 million and an average share price of $115.04.

LIQUIDITY/CAPITAL:

Globe Life's operations consist primarily of writing basic protection life and supplemental health insurance policies which generate strong and stable cash flows. These cash flows are not impacted by volatile equity markets. Liquidity at the Parent Company is sufficient to meet additional capital needs of the insurance companies.

EARNINGS GUIDANCE FOR THE YEAR ENDING December 31, 2023:

New accounting guidance related to long-duration insurance contracts became effective January 1, 2023. Under this new requirement, Globe Life projects net operating income between $10.28 to $10.52 per diluted common share for the year ending December 31, 2023.

NON-GAAP MEASURES:

In this news release, Globe Life includes non-GAAP measures to enhance investors' understanding of management's view of the business. The non-GAAP measures are not a substitute for GAAP, but rather a supplement to increase transparency by providing broader perspective. Globe Life's definitions of non-GAAP measures may differ from other companies' definitions. More detailed financial information, including various GAAP and non-GAAP measurements, is located at https://investors.globelifeinsurance.com on the Investors page under “Financial Reports and Other Financial Information."


9
GL Q1 2023 Earnings Release


CAUTION REGARDING FORWARD-LOOKING STATEMENTS:

This press release may contain forward-looking statements within the meaning of the federal securities laws, including statements related to the expected impact of the COVID-19 outbreak on our business operations, financial results and financial condition. These prospective statements reflect management’s current expectations, but are not guarantees of future performance. Whether or not actual results differ materially from forward-looking statements may depend on numerous foreseeable and unforeseeable events or developments, which may be national in scope, related to the insurance industry generally, or applicable to the Company specifically. Such events or developments could include, but are not necessarily limited to:

1) Economic and other conditions, including the COVID-19 pandemic and its impact on the U.S. economy, leading to unexpected changes in lapse rates and/or sales of our policies, as well as levels of mortality, morbidity, and utilization of health care services that differ from Globe Life's assumptions;

2) Regulatory developments, including changes in accounting standards or governmental regulations (particularly those impacting taxes and changes to the Federal Medicare program that would affect Medicare Supplement);

3) Market trends in the senior-aged health care industry that provide alternatives to traditional Medicare (such as Health Maintenance Organizations and other managed care or private plans) and that could affect the sales of traditional Medicare Supplement insurance;

4) Interest rate changes that affect product sales and/or investment portfolio yield;

5) General economic, industry sector or individual debt issuers’ financial conditions (including developments and volatility arising from the COVID-19 pandemic, particularly in certain industries that may comprise part of our investment portfolio) that may affect the current market value of securities we own, or that may impair an issuer’s ability to make principal and/or interest payments due on those securities;

6) Changes in pricing competition;

7) Litigation results;

8) Levels of administrative and operational efficiencies that differ from our assumptions (including any reduction in efficiencies resulting from increased costs arising from operating during the COVID-19 pandemic);

9) The ability to obtain timely and appropriate premium rate increases for health insurance policies from our regulators;

10) The customer response to new products and marketing initiatives;

11) Reported amounts in the consolidated financial statements which are based on management estimates and judgments which may differ from the actual amounts ultimately realized;

12) Compromise by a malicious actor or other event that causes a loss of secure data from, or inaccessibility to, our computer and other information technology systems;

13) The severity, magnitude and impact of the COVID-19 pandemic, including effects of the pandemic and the effects of the U.S. government’s and other businesses’ response to the pandemic, on our operations and personnel, and on commercial activity and demand for our products; and

14) Globe Life’s ability to access the commercial paper and debt markets, particularly if such markets become unpredictable or unstable for a certain period.

Readers are also directed to consider other risks and uncertainties described in other documents on file with the Securities and Exchange Commission. Globe Life specifically disclaims any obligation to update or revise any forward-looking statement because of new information, future developments or otherwise.
10
GL Q1 2023 Earnings Release


EARNINGS RELEASE CONFERENCE CALL WEBCAST:

Globe Life will provide a live audio webcast of its first quarter 2023 earnings release conference call with financial analysts at 11:00 am (Eastern) tomorrow, May 4, 2023. Access to the live webcast and replay will be available at https://investors.globelifeinsurance.com on the Calls and Meetings page, at the Conference Calls on the Web icon. Immediately following this press release, supplemental financial reports will be available before the conference call on the Investors page menu of the Globe Life website at “Financial Reports.”
For additional information contact:
Mike Majors, Executive Vice President - Policy Acquisition and Chief Strategy Officer
Globe Life Inc.
3700 South Stonebridge Drive
P. O. Box 8080
McKinney, Texas 75070-8080
Phone: 972-569-3627 or email: investors@globe.life
Website: https://investors.globelifeinsurance.com

11
GL Q1 2023 Earnings Release

GLOBE LIFE INC.
Earnings Release—Q1 2023
(Dollar amounts in thousands, except share and per share data)
(Unaudited)
APPENDIX

GLOBE LIFE INC.
GAAP CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
Three Months Ended
March 31,
 2023
2022(1)
Revenue:
Life premium$772,597 $749,128 
Health premium322,493 315,684 
Other premium— — 
Total premium1,095,090 1,064,812 
Net investment income257,105 244,894 
Realized gains (losses)(30,927)(7,244)
Other income50 164 
Total revenue1,321,318 1,302,626 
Benefits and expenses:
Life policyholder benefits (net of remeasurement (gain) loss: 2023—$(2,697); 2022—$5,783)
507,977 495,429 
Health policyholder benefits (net of remeasurement (gain) loss: 2023—$2,038; 2022—$(1,959))
190,962 189,018 
Other policyholder benefits8,988 9,702 
Total policyholder benefits707,927 694,149 
Amortization of deferred acquisition costs92,322 84,496 
Commissions, premium taxes, and non-deferred acquisition costs137,797 125,509 
Other operating expense84,171 84,352 
Interest expense24,867 19,944 
Total benefits and expenses1,047,084 1,008,450 
Income before income taxes274,234 294,176 
Income tax benefit (expense)(50,624)(56,692)
Net income$223,610 $237,484 
Basic net income per common share$2.32 $2.39 
Diluted net income per common share$2.28 $2.37 

(1)The amounts presented for 2022 have been retrospectively restated due to the adoption of the LDTI standard.

12
GL Q1 2023 Earnings Release
EX-101.SCH 3 gl-20230503.xsd XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT 0000001 - Document - Cover page link:presentationLink link:calculationLink link:definitionLink EX-101.DEF 4 gl-20230503_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT EX-101.LAB 5 gl-20230503_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT Entity Listings [Line Items] Entity Listings [Line Items] Entity Address, State or Province Entity Address, State or Province Entity Tax Identification Number Entity Tax Identification Number Title of 12(b) Security Title of 12(b) Security Entity File Number Entity File Number 4.250% Junior Subordinated Debentures Subordinated Debt [Member] Written Communications Written Communications Entity Emerging Growth Company Entity Emerging Growth Company Soliciting Material Soliciting Material City Area Code City Area Code Entity Incorporation, State or Country Code Entity Incorporation, State or Country Code Entity Address, Address Line One Entity Address, Address Line One Local Phone Number Local Phone Number Cover page. Cover [Abstract] Pre-commencement Tender Offer Pre-commencement Tender Offer Entity Listings [Table] Entity Listings [Table] Amendment Flag Amendment Flag Common Stock, $1.00 par value per share Common Stock [Member] Pre-commencement Issuer Tender Offer Pre-commencement Issuer Tender Offer Trading Symbol Trading Symbol Document Period End Date Document Period End Date Class of Stock [Domain] Class of Stock [Domain] Document Type Document Type Class of Stock [Axis] Class of Stock [Axis] Entity Registrant Name Entity Registrant Name Entity Address, City or Town Entity Address, City or Town Entity Address, Postal Zip Code Entity Address, Postal Zip Code Entity Central Index Key Entity Central Index Key Security Exchange Name Security Exchange Name EX-101.PRE 6 gl-20230503_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT GRAPHIC 7 globelifeheadera.gif begin 644 globelifeheadera.gif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end XML 8 R1.htm IDEA: XBRL DOCUMENT v3.23.1
Cover page
May 03, 2023
Entity Listings [Line Items]  
Document Type 8-K
Document Period End Date May 03, 2023
Entity Registrant Name GLOBE LIFE INC.
Entity Incorporation, State or Country Code DE
Entity File Number 001-08052
Entity Tax Identification Number 63-0780404
Entity Address, Address Line One 3700 South Stonebridge Drive
Entity Address, City or Town McKinney
Entity Address, State or Province TX
Entity Address, Postal Zip Code 75070
City Area Code 972
Local Phone Number 569-4000
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Entity Emerging Growth Company false
Entity Central Index Key 0000320335
Amendment Flag false
Common Stock, $1.00 par value per share  
Entity Listings [Line Items]  
Title of 12(b) Security Common Stock, $1.00 par value per share
Trading Symbol GL
Security Exchange Name NYSE
4.250% Junior Subordinated Debentures  
Entity Listings [Line Items]  
Title of 12(b) Security 4.250% Junior Subordinated Debentures
Trading Symbol GL PRD
Security Exchange Name NYSE
XML 9 gl-20230503_htm.xml IDEA: XBRL DOCUMENT 0000320335 2023-05-03 2023-05-03 0000320335 us-gaap:CommonStockMember 2023-05-03 2023-05-03 0000320335 us-gaap:SubordinatedDebtMember 2023-05-03 2023-05-03 0000320335 false 8-K 2023-05-03 GLOBE LIFE INC. DE 001-08052 63-0780404 3700 South Stonebridge Drive McKinney TX 75070 972 569-4000 false false false false Common Stock, $1.00 par value per share GL NYSE 4.250% Junior Subordinated Debentures GL PRD NYSE false 2023-05-03 2023-05-03 EXCEL 10 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 11 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 12 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 13 FilingSummary.xml IDEA: XBRL DOCUMENT 3.23.1 html 3 22 1 false 2 0 false 0 false false R1.htm 0000001 - Document - Cover page Sheet http://www.globelifeinsurance.com/role/Coverpage Cover page Cover 1 false false All Reports Book All Reports gl-20230503.htm gl-20230503.xsd gl-20230503_def.xml gl-20230503_lab.xml gl-20230503_pre.xml q1fy2023earningsrelease.htm http://xbrl.sec.gov/dei/2021 true false JSON 15 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "gl-20230503.htm": { "axisCustom": 0, "axisStandard": 1, "baseTaxonomies": { "http://xbrl.sec.gov/dei/2021": 27 }, "contextCount": 3, "dts": { "definitionLink": { "local": [ "gl-20230503_def.xml" ] }, "inline": { "local": [ "gl-20230503.htm" ] }, "labelLink": { "local": [ "gl-20230503_lab.xml" ] }, "presentationLink": { "local": [ "gl-20230503_pre.xml" ] }, "schema": { "local": [ "gl-20230503.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd", "https://xbrl.fasb.org/srt/2021/elts/srt-roles-2021-01-31.xsd", "https://xbrl.fasb.org/srt/2021/elts/srt-types-2021-01-31.xsd", "https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd", "https://xbrl.fasb.org/us-gaap/2021/elts/us-roles-2021-01-31.xsd", "https://xbrl.fasb.org/us-gaap/2021/elts/us-types-2021-01-31.xsd", "https://xbrl.sec.gov/country/2021/country-2021.xsd", "https://xbrl.sec.gov/dei/2021/dei-2021.xsd" ] } }, "elementCount": 29, "entityCount": 1, "hidden": { "http://xbrl.sec.gov/dei/2021": 2, "total": 2 }, "keyCustom": 0, "keyStandard": 22, "memberCustom": 0, "memberStandard": 2, "nsprefix": "gl", "nsuri": "http://www.globelifeinsurance.com/20230503", "report": { "R1": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "gl-20230503.htm", "contextRef": "iee8c91817efb44af8f195855b8c5ebf8_D20230503-20230503", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "0000001 - Document - Cover page", "menuCat": "Cover", "order": "1", "role": "http://www.globelifeinsurance.com/role/Coverpage", "shortName": "Cover page", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "gl-20230503.htm", "contextRef": "iee8c91817efb44af8f195855b8c5ebf8_D20230503-20230503", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 2, "tag": { "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag", "terseLabel": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.globelifeinsurance.com/role/Coverpage" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area code of city", "label": "City Area Code", "terseLabel": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.globelifeinsurance.com/role/Coverpage" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cover page.", "label": "Cover [Abstract]", "terseLabel": "Cover page." } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2021", "xbrltype": "stringItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.", "label": "Document Period End Date", "terseLabel": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.globelifeinsurance.com/role/Coverpage" ], "xbrltype": "dateItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type", "terseLabel": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.globelifeinsurance.com/role/Coverpage" ], "xbrltype": "submissionTypeItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One", "terseLabel": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.globelifeinsurance.com/role/Coverpage" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town", "terseLabel": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.globelifeinsurance.com/role/Coverpage" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code", "terseLabel": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.globelifeinsurance.com/role/Coverpage" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address, State or Province", "terseLabel": "Entity Address, State or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.globelifeinsurance.com/role/Coverpage" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key", "terseLabel": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.globelifeinsurance.com/role/Coverpage" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company", "terseLabel": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.globelifeinsurance.com/role/Coverpage" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number", "terseLabel": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.globelifeinsurance.com/role/Coverpage" ], "xbrltype": "fileNumberItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation, State or Country Code", "terseLabel": "Entity Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.globelifeinsurance.com/role/Coverpage" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityListingsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Entity Listings [Line Items]", "terseLabel": "Entity Listings [Line Items]" } } }, "localname": "EntityListingsLineItems", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.globelifeinsurance.com/role/Coverpage" ], "xbrltype": "stringItemType" }, "dei_EntityListingsTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Container for exchange listing information for an entity", "label": "Entity Listings [Table]", "terseLabel": "Entity Listings [Table]" } } }, "localname": "EntityListingsTable", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.globelifeinsurance.com/role/Coverpage" ], "xbrltype": "stringItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name", "terseLabel": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.globelifeinsurance.com/role/Coverpage" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number", "terseLabel": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.globelifeinsurance.com/role/Coverpage" ], "xbrltype": "employerIdItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number", "terseLabel": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.globelifeinsurance.com/role/Coverpage" ], "xbrltype": "normalizedStringItemType" }, "dei_PreCommencementIssuerTenderOffer": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.", "label": "Pre-commencement Issuer Tender Offer", "terseLabel": "Pre-commencement Issuer Tender Offer" } } }, "localname": "PreCommencementIssuerTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.globelifeinsurance.com/role/Coverpage" ], "xbrltype": "booleanItemType" }, "dei_PreCommencementTenderOffer": { "auth_ref": [ "r3" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.", "label": "Pre-commencement Tender Offer", "terseLabel": "Pre-commencement Tender Offer" } } }, "localname": "PreCommencementTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.globelifeinsurance.com/role/Coverpage" ], "xbrltype": "booleanItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r0" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Title of 12(b) Security", "terseLabel": "Title of 12(b) Security" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.globelifeinsurance.com/role/Coverpage" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name", "terseLabel": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.globelifeinsurance.com/role/Coverpage" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_SolicitingMaterial": { "auth_ref": [ "r4" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.", "label": "Soliciting Material", "terseLabel": "Soliciting Material" } } }, "localname": "SolicitingMaterial", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.globelifeinsurance.com/role/Coverpage" ], "xbrltype": "booleanItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol", "terseLabel": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.globelifeinsurance.com/role/Coverpage" ], "xbrltype": "tradingSymbolItemType" }, "dei_WrittenCommunications": { "auth_ref": [ "r6" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.", "label": "Written Communications", "terseLabel": "Written Communications" } } }, "localname": "WrittenCommunications", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.globelifeinsurance.com/role/Coverpage" ], "xbrltype": "booleanItemType" }, "us-gaap_ClassOfStockDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Class of Stock [Domain]", "terseLabel": "Class of Stock [Domain]" } } }, "localname": "ClassOfStockDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.globelifeinsurance.com/role/Coverpage" ], "xbrltype": "domainItemType" }, "us-gaap_CommonStockMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Common Stock [Member]", "terseLabel": "Common Stock, $1.00 par value per share" } } }, "localname": "CommonStockMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.globelifeinsurance.com/role/Coverpage" ], "xbrltype": "domainItemType" }, "us-gaap_StatementClassOfStockAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Class of Stock [Axis]", "terseLabel": "Class of Stock [Axis]" } } }, "localname": "StatementClassOfStockAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.globelifeinsurance.com/role/Coverpage" ], "xbrltype": "stringItemType" }, "us-gaap_SubordinatedDebtMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Subordinated Debt [Member]", "terseLabel": "4.250% Junior Subordinated Debentures" } } }, "localname": "SubordinatedDebtMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.globelifeinsurance.com/role/Coverpage" ], "xbrltype": "domainItemType" } }, "unitCount": 0 } }, "std_ref": { "r0": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r1": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r2": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "13e", "Subsection": "4c", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r3": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14d", "Subsection": "2b", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r4": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14a", "Subsection": "12", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r5": { "Name": "Regulation 12B", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r6": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "425", "role": "http://www.xbrl.org/2003/role/presentationRef" } }, "version": "2.2" } ZIP 16 0000320335-23-000027-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0000320335-23-000027-xbrl.zip M4$L#!!0 ( !R%HU;G/O.G0A< +N@ / 9VPM,C R,S U,#,N:'1M M[3UK=]JZLM_/K]#EW'M.NE8%MFQCF[8Y*PTDA[UKTQ"2;/.E2[;D8&(PVS;A M\>OOR(8$ DG)BR1MVK5:0*_1O#0S&DF?_S/NA>B2QTD0];\4Y*)40/_9_?P_ M&/_UM?D-52-OV./]%.W'G*:S&83'A7O$\NBQ!00G E0NSBJ+PNNIH-"IF MU:/X'*I)2BGH)RGM>WQ>/QC?5ED6E<.@SP4N%[MG-T"9]5TNY85759-E.$;* MO*9<^LOZ=NQU>(_B57C2]0!=PU)*8]I/_"CNT13H+J8O88E@FL;)IF M:2PP.A]IF.!S2@=7E7V:N%G564&&5BS)6+E"+D!P<0=N1;%+DZNYC%?J+P$C M2A>FC8&D2Y7G)+YKYK*&)6,.826D_?,O!=[')\<%8!].V>[G'D\I$KUB_O

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